// App-Quantinova.ai

P673 : Vedolizumab dose escalation as a way of recapturing response in patients with inflammatory bowel disease

Researchers

Presenter

  • M Sierra Morales

Principal Investigators

  • S Birdi

  • M A Samaan

  • C Brown-Clarke

  • J Duncan

  • A Stanton

  • I Koumoutsos

  • S Anderson

  • S Ray

  • J Mawdsley

  • J Sanderson

  • P M Irving

Medical Centers

  • Guy's and St Thomas' NHS Foundation Trust, Gastroenterology, London, United Kingdom

  • Hospital Universitario Ramon y Cajal, Gastroenterology, Madrid, Spain

Locations

  • United Kingdom

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • C reactive protein

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • Dose Escalation

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved